Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

U.S. aims to cut dialysis in centers, increase transplants by 2025

The Trump administration plans to change the way it pays for kidney disease treatments to favor lower cost care at home and transplants over the current standard, dialysis clinics, top health officials said during a press briefing.

Read More »

Insys Therapeutics Files for Bankruptcy

Days after agreeing to pay nearly $225 million in additional fines to the U.S. government for fraudulent marketing schemes to boost sales of the opioid Subsys, Insys Therapeutics filed for bankruptcy.

Read More »

Without older subjects, cancer drug trials rely on atypical patients

Cancer drug study patients tend to be younger than most people with the disease in the general population.

Read More »

Report Shows U.S. Drug Spending Expected to Increase in 2019 and in Years to Come

Despite saber-rattling, Congressional hearings, public shaming, rules regarding pricing transparency and more, the cost of spending on prescription drugs in the United States has actually increased and will likely do so for the next several years.

Read More »

Exclusive: Canada told drugmakers that government would limit scope of some new price rules

The Canadian government has assured the pharmaceutical industry that new features of its plan to cut drug costs would apply only to new medicines, Health Canada said, offering some relief to drugmakers even as other regulations could still lower prices of medicines already on the market.

Read More »

U.S. finalizes rule requiring drug prices in TV spots

The Trump administration will require drugmakers to disclose the list price of prescription drugs in DTC TV advertisements, part of the government’s efforts to lower costs for U.S. consumers.

Read More »

U.S. sues Rochester drug distributor over suspicious opioid orders

The U.S. government filed a civil lawsuit accusing Rochester Drug-Cooperative Inc., a large opioid distributor, of failing to report thousands of suspicious orders for controlled substances as part of a years-long drive to bolster profit.

Read More »

U.S. charges 24 in telemedicine healthcare fraud resulting in losses of $1.2+ billion

U.S. authorities said 24 defendants were charged in connection with one of the largest healthcare fraud schemes prosecuted by the federal government, involving telemedicine companies and resulting in more than $1.2 billion of losses.

Read More »

Obamacare enrollments drop marginally for 2019

Enrollments in healthcare plans for 2019 through the Federal Obamacare marketplace dropped marginally by 300,000 from 2018, according to U.S. government figures.

Read More »

Philippines to charge officials of Sanofi, government over deaths linked to vaccine

The Philippine Department of Justice has found probable cause to indict officials from French drugmaker Sanofi and former and current Philippine health officials over 10 deaths the department said were linked to use of a dengue vaccine.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom